跳至主要内容
临床试验/NCT04833270
NCT04833270已完成不适用

Pragmatic Randomized Controlled Trial of Non-pharmacological Treatment for Lumbar Disc Herniation : A Pilot Study

Jaseng Hospital of Korean Medicine2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2021年7月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
2
主要终点
Numeric rating scale (NRS) of radiating pain in lower extremities

研究概览

简要总结

This is a 2-arm parallel pragmatic randomized controlled trial that will compare non-pharmacological treatment with pharmacological therapy for lumbar disc herniation.

详细描述

Participants who voluntarily signed informed consent form and eligible for the study were randomly assigned in a 1:1 ratio (15:15) for non-pharmacological treatment and pharmacological treatment group. Participants of each group will receive twice a week for total 8 weeks of intervention. This is a pragmatic randomized controlled trial, so physicians will have medical decision making according to each participant's conditions and choose the specific intervention and dosage of pharmacological and non-pharmacological treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
19 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Numeric rating scale (NRS) score of radiating pain 5 or more for recent 3 serial days.
  • Onset time of radiating pain occurred within 12 weeks.
  • Radiologically diagnosed with lumbar disc herniation in lumbar spine magnetic resonance imaging (L-spine MRI)
  • 19-70 years old
  • participants who agreed and signed informed consent form

排除标准

  • Spine metastasis of cancer, acute fracture of spine, or spine dislocation
  • Progressive neurologic deficits or severe neurologic deficits
  • Soft tissue diseases that can induce low back pain(ie. cancer, fibromyalgia, rheumatoid arthritis, gout,etc)
  • Presence of chronic underlying disease which can interfere the efficacy or interpretation (ie. stroke, myocardial infarct, kidney disease, dementia, diabetic neuropathy, epilepsy, etc)
  • Concurrent use of steroids, immunosuppressants, orpsychotropic medications or any other medication that can interrupt the study result
  • Hemorrhagic disease, severe diabetes or taking anticoagulant drug
  • Participants who took NSAIDs or pharmacopuncture within 1 week
  • Pregnant or lactating women
  • Participants who had undergone lumbar surgery within 3 months
  • Participants who had participated in other clinical trial within 1 month, or have plan for participation in other trial during follow up period of this trial
  • Participants who can not write informed consent
  • Participants who is difficult to participate in the trial according to investigator's decision

结局指标

主要结局

Numeric rating scale (NRS) of radiating pain in lower extremities

时间窗: week 9

NRS is a pain scale in which the patient indicates their subjective pain as awhole number from 0 to 10, where 0 indicates 'no pain or discomfort' and10 indicates 'the most severe pain and discomfort imaginable'.

次要结局

  • Numeric rating scale (NRS) of radiating pain in lower extremities(week 1, 2, 3, 4, 5, 6, 7, 8, 9, 14, 27)
  • Visual analogue scale (VAS) of low-back pain(week 1, 2, 3, 4, 5, 6, 7, 8, 9, 14, 27)
  • Short Form-12 Health Survey version 2 (SF-12 v2)(week 1, 5, 9, 14, 27)
  • Numeric rating scale (NRS) of low-back pain(week 1, 2, 3, 4, 5, 6, 7, 8, 9, 14, 27)
  • Visual analogue scale (VAS) of leg radiating pain(week 1, 2, 3, 4, 5, 6, 7, 8, 9, 14, 27)
  • Oswestry Disability Index (ODI)(week 1, 5, 9, 14, 27)
  • Patient Global Impression of Change (PGIC)(week 9, 14, 27)
  • Fear-Avoidance Beliefs Questionnaire (FABQ)(week 1, 9, 14, 27)
  • EuroQol-5 Dimension (EQ-5D-5L)(week 1, 5, 9, 14, 27)

研究者

发起方
Jaseng Hospital of Korean Medicine
申办方类型
Other
责任方
Principal Investigator
主要研究者

Kyoung Sun Park

Chief, Clinical study center

Jaseng Hospital of Korean Medicine

研究点 (2)

Loading locations...

相似试验